Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Losartan. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101519411A details a one-pot lithiation method for high-purity Losartan intermediates, offering significant cost reduction and supply chain reliability for API manufacturing.
This patent details a novel purification method for Losartan achieving 99.5% purity. It offers significant cost reduction and supply chain reliability for pharmaceutical manufacturers seeking high-quality intermediates.
Patent CN101328167A reveals a streamlined Losartan synthesis using strong acid deprotection and borohydride reduction, offering cost-effective manufacturing solutions.
Patent CN1097419A discloses a robust route for imidazole derivatives, offering cost-effective manufacturing solutions for reliable pharmaceutical intermediate suppliers globally.
Patent CN107056756B reveals a method achieving 98.4% purity using cyclic amine catalysts, offering significant cost reduction and scalability for API manufacturing.
Patent CN105198863B reveals a novel crystallization method for Losartan, achieving 99.5% purity without salt conversion, offering significant cost reduction in API manufacturing.
Patent CN101519411B details high purity synthesis. Offers cost reduction and scalable supply for pharmaceutical intermediates manufacturing globally.
Discover a novel oxidation method for Losartan metabolite EXP-3174 offering high purity and yield. Ideal for cost reduction in API manufacturing and scalable supply.
Patent CN1832931A reveals a safer process for phenyltetrazole intermediates. Discover cost reduction in pharma manufacturing and reliable supply chain solutions.
Novel zinc-mediated debromination process for biphenyl compounds offers high yield and mother liquor recycling for cost-effective Sartan intermediate manufacturing.
Discover the novel catalytic route for Losartan synthesis in patent CN1915990B. Eliminate protection steps for significant cost reduction and high-purity API intermediate supply.
Patent CN111592495A reveals a green 3-step route for Losartan intermediate. Achieve high purity with reduced phosphorus waste and lower manufacturing costs.
Patent CN1931857A reveals a scalable permanganate oxidation route for Losartan 5-carboxylate (EXP-3174), offering high purity and eliminating chromatography for cost-effective API manufacturing.
Patent CN108047208B reveals a novel acid-hydrolysis method reducing losartan dimer impurities below 0.1%, offering significant cost reduction in pharmaceutical intermediates manufacturing.
Patent CN110372544B details a cost-effective iron-titanium catalytic system for biaryl synthesis, offering significant supply chain stability and reduced environmental impact.